Articles On Eve Investments (ASX:EVE)
Title | Source | Codes | Date |
---|---|---|---|
Hot Money Monday: ASX is best place in the world to profit from momentum strategy, says this fundie
A momentum trader will essentially be “buying high, but hoping to sell even higher” – which is the counter to the well known strategy of “buy low and sell high”. The biggest question for momentum traders is therefore how to find those stock... |
Stockhead | EVE | 10 months ago |
EVE Health (ASX:EVE) flags capital raise
EVE Health Group (EVE) has entered a trading halt after announcing its intention to raise fresh capital The health and wellness company ended the December quarter with $941,000 in cash and one quarter left of funding and said it was assess... |
themarketherald.com.au | EVE | 2 years ago |
Closing Bell: Markets await Russia conflict updates as US stock futures push higher
After the Russia-Ukraine crisis sent US investors back into their shell overnight, ASX investors were comparatively sanguine in Friday trade. Large caps still finished in the red, but a host of gains among junior explorers saw the microcap... |
Stockhead | EVE | 2 years ago |
EVE Health Group (ASX:EVE) reports half year revenue boost for Meluka Australia
EVE Health Group (EVE) provides an unaudited half yearly update for its subsidiary, Meluka Australia, reporting an increase in revenue of 34 per cent to $750,000 It reports Australian revenue is up 359 per cent, US revenue is up 21 per cen... |
themarketherald.com.au | EVE | 2 years ago |
Closing Bell: ASX finishes slightly higher despite a big drop in tech
After trading down for most of the day, the ASX ultimately closed higher despite a big sell off in tech. The ASX 200 closed at 7,245 points which was 0.05% higher than Friday. Tech retreated 2.2% over inflation fears but gains of over 1.9%... |
Stockhead | EVE | 3 years ago |
Market Highlights and 5 ASX Small Caps to watch on Monday
US stocks tumbled on Friday All three major US stock markets tumbled on Friday, as mega tech stocks fell hard. The Nasdaq was down by 1.92%, the S&P500 by 0.85%, and the Dow Jones index by 0.17%. Weak non-farm payrolls added to the unce... |
Stockhead | EVE | 3 years ago |
Closing Bell: ASX fails to maintain gains, despite tech gaining 1.7pc
Just like yesterday the ASX rallied for most of the day but retreated in the afternoon and today closed in the red. The ASX 200 was down 0.08% at 7,375 points. Another difference from yesterday was tech was the best sector gaining 1.7% whil... |
Stockhead | EVE | 3 years ago |
Reporting Season Round Up: Leading the charge on the ASX was an $8m honey-based product exporter
Of all the ASX stocks releasing quarterlies or general financial updates this morning, honey and honey-based product exporter Eve Investments (ASX:EVE) impressed the most. EVE Investments (ASX:EVE) This microcap stock rose as much as 60%... |
Stockhead | EVE | 3 years ago |
10 at 10: These ASX stocks have floated up high this morning
Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov... |
Stockhead | EVE | 3 years ago |
Weed Week: Cannabis business degrees, cornering Germany’s €200M market and Hanks Kerchiefs hits stores
The Community College of Denver (CCD) has just launched a cannabis business program in Colorado. The new program offers students the opportunity to earn an Associate of Applied Science degree designed to prepare them to become business mana... |
Stockhead | EVE | 3 years ago |
Health and Wellness: Post-pandemic drivers, investment thematics and risks
On the Bid is a new Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Oriel Morrison discusses the rapidly growing potash market. Populating the expert panel this wee... |
Stockhead | EVE | 3 years ago |
Five shining ASX penny stocks in today’s session
Summary GBR share price has skyrocketed by a massive 91.3% to AU$0.088. Eve Investments’ confirmed first purchase order has led its share price to rise by 16.67% to AU$0.007. BOE’s share price opened with a gap and surpassed its 52-we... |
Kalkine Media | EVE | 3 years ago |
10 at 10: These ASX stocks have navigated the market turbulence the most successfully this morning
Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov... |
Stockhead | EVE | 3 years ago |
Eve Investments delivers on expansion promises with Whole Foods roll out
Eve Investments (ASX:EVE) has confirmed its roll out into American multinational supermarket chain Whole Foods with two products to be ranged in all 48 stores in Whole Foods’ North Western California network. The products will launch in sto... |
Stockhead | EVE | 3 years ago |
Weed Week: Australian medical cannabis prescriptions are soaring
The number of medical cannabis prescriptions issued under Australia’s special access scheme just keeps on growing. There were a record 9,959 SAS Category B marijuana prescriptions issued in March, two and a half times the number from a year... |
Stockhead | EVE | 3 years ago |
Eve Investments reports record quarter boosted by Amazon online sales
Special Report: Eve Investments reports record sales in USA, Australia in its December 2020 Quarterly Update. ... Read More The post Eve Investments reports record quarter boosted by Amazon online sales appeared first on Stockhead. |
Stockhead | EVE | 3 years ago |
Omni Innovation gets green light for multi-country distribution deal
Special Report: Omni Innovation, an Australian company specialising in medical nutrition, 38% owned by Eve Investments, has entered a licencing ... Read More The post Omni Innovation gets green light for multi-country distribution deal appe... |
Stockhead | EVE | 3 years ago |
Meluka’s honey flying off the shelves in China
Special Report: Meluka Australia has chalked up another major milestone by selling out its entire second shipment of honey to China before it could be delivered. Australian owned and operated health and wellness company Meluka Australia, a... |
Stockhead | EVE | 4 years ago |
A Fistful of Dollars: Fiji Kava & EVE Investments surge on rosy outlook
Fiji Kava (ASX:FIJ) and EVE Investments (ASX:EVE) both surged in morning trade after revealing more money would be coming their way. Organic honey producer EVE updated shareholders on its China sales, saying that the latest shipment had bee... |
Stockhead | EVE | 4 years ago |
10 at 10: These ASX stocks are sky high this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | EVE | 4 years ago |
Weed Week: Cannabis for kids? UK baby participates in world-first treatment
For the many companies in Australia’s medicinal cannabis sector, the health benefits of cannabidiol (CBD) products are self-evident. But a trial underway in the UK is also testing the safety and efficiency of cannabis-derived medicines to t... |
Stockhead | EVE | 4 years ago |
Stocks Tapping The Wellness Boom
By Tim Boreham, Editor, The New Criterion Organic growth: the next generation of stocks tapping the “wellness” boom Usually referred to in the same breath as health, “wellness” is an amorphous term but that hasn’t stopped investors from flo... |
FNArena | EVE | 4 years ago |
StockTalk: The beneficiaries of China’s economic bounce-back
StockTalk is a new Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Dr Nigel Finch discusses China’s rebounding economy and the companies, sectors and industries bes... |
Stockhead | EVE | 4 years ago |
New probiotic bio-fermented drink ‘the bee’s knees’ in lucrative market
Special Report: ASX-listed health, nutrition and wellness company, EVE Investments, has launched its probiotic bio-fermented honey drink in Australia as the US and Japan wait in the wings. Capitalising on a groundswell for diversified healt... |
Stockhead | EVE | 4 years ago |
Coronavirus spurs China’s appetite for our tea tree oil, hand sanitiser, honey, medicine, technology
Promising green shoots are appearing amid tumbling stocks as China reaches out to Australian producers amid the coronavirus outbreak. While it’s doom and gloom in Australia’s retail sector, it’s a different story in some of the smaller sto... |
Stockhead | EVE | 4 years ago |
Health Kick Podcast: The ASX’s only medicinal honey player and the advantage of Amazon-aided US exposure
Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment of The Health Kick Podcast. In this episode Tim chats with Bill Fry, managing director of Eve Inv... |
Stockhead | EVE | 4 years ago |
Aussie micro on New Year high after landing first China customers
Special Report: ASX-listed health and wellness company, EVE Investments, has secured its first purchase orders in China for over 21,000 units of Meluka Honey as the company unveils a new product range and announces further plans for growth.... |
Stockhead | EVE | 4 years ago |
Aussie Micro seeing sweet distribution potential in China
Special Report: Fresh off the back of securing a $9.3 million strategic placement, diversified health and wellness investment group EVE Investments is scaling up its commercialisation in the Asia Pacific region with a strategic expansion in... |
Stockhead | EVE | 5 years ago |
Weed Week: The great German bake-off
Each week our Weed Week column wraps the news driving ASX cannabis stocks. Angela Merkel’s ruling conservative Christian Democratic Union (CDU) party might be contemplating a move to legalise cannabis in Germany, DW reported last week. “Can... |
Stockhead | EVE | 5 years ago |
Weed Week: Australia’s cannabis legalisation is all over the joint
It’s been another interesting week in the realm of Australian cannabis regulation. For starters, the ACT legislature’s recent decision to legalise marijuana possession (up to a maximum of 50 grams) continued to grab some headlines. Senior m... |
Stockhead | EVE | 5 years ago |
Rise & Shine: What you need to know before the ASX opens
On Stockhead today: our report on the 100 best performing stocks for the year, how four directors put in $5.1 million to make a quick $1.4 million, what are the hottest stocks on the ASX right now and Dr Boreham’s prognosis of Suda. But fir... |
Stockhead | EVE | 5 years ago |
Rise & Shine: What you need to know before the ASX opens
On Stockhead today, why the ASX thinks the tech IPO story has further to run, McKinsey & Co say private equity needs to get more entrepreneurial and while low interest rates might make wealth creation harder, it’s not impossible, expert... |
Stockhead | EVE | 5 years ago |
Weed Week: US looks at ways to help cannabis players get banking access
Taking the cannabis market to the next level, the US is now taking a closer look at the industry’s lack of access to financial services. Forbes reported on Tuesday that a Republican-controlled Senate committee had scheduled a hearing for ne... |
Stockhead | EVE | 5 years ago |
Weed Week: American rapper Jay-Z is throwing his weight behind cannabis
Californian cannabis company Caliva has signed on billionaire rapper Shawn “Jay-Z” Carter to promote its brand as the drug becomes legal recreationally in more states. Caliva said Jay-Z, as the company’s chief brand strategist, would “play... |
Stockhead | EVE | 5 years ago |
Updates on Two Cannabis Stocks- THC & AC8
Cannabis Industry in Australia has been flourishing for some time now, and the Australian regulators have been gung-ho on the medicinal use of cannabis. The progress and competition would gradually rise every day with companies unlocking th... |
Kalkine Media | EVE | 5 years ago |
THC Global obtains licence for Australia’s largest medicinal cannabis facility
Australian medicinal cannabis developer THC Global (ASX: THC) has been granted a second manufacturing licence, this time for its large Southport facility, making it the largest licenced bio-pharma extraction facility in the Southern Hemisph... |
SmallCaps | EVE | 5 years ago |
6 Cannabis Stocks For Australia- THC, EOF, MRG, SUD, CPH, EXL
Globally, the cannabis market is estimated to be valued at around USD 150 billion. According to the European Consumer Staples Report released by Barclays in September 2018, the market value could shoot up, and may staggeringly increase to U... |
Kalkine Media | EVE | 5 years ago |
Top 10 at 10: These ASX small caps are climbing fast today
At the start of every trading day, it can be useful to know which stocks are humming out of the gate. Often, the moves are part of the usual market ructions in small caps, but sometimes a big announcement can cause a stock to rocket higher... |
Stockhead | EVE | 5 years ago |
The Pot Seat: The 9 key things we know now about Aussie cannabis
Honey containing THC *might* be able to be exported and imported. The UK is the Next Big Thing in pot, Brexit or no. And 2020 is starting to look like a very hard deadline for a series of big events. There are 30 companies doing, or saying... |
Stockhead | EVE | 5 years ago |
The Pot Seat distilled: The 9 key things we know now about Aussie cannabis
Honey containing THC *might* be able to be exported and imported. The UK is the Next Big Thing in pot, Brexit or no. And 2020 is starting to look like a very hard deadline for a series of big events. There are 30 companies doing, or saying... |
Stockhead | EVE | 5 years ago |
THC Global's new manufacturing licence a boost for cannabis honey products
Eve Investments, via agreements with THC Global, now has a viable option to access THC’s cannabis licensing for research and development of its products. |
Proactive Investors | EVE | 5 years ago |
THC Global and Eve Investments to advance medicinal cannabis partnership following manufacturing licence
In the wake of THC Global (ASX: THC) reporting it has secured its medicinal cannabis manufacturing licence, partner Eve Investments (ASX: EVE) noted the licence now paves the way for the duo to advance existing site lease, tea-tree and cann... |
SmallCaps | EVE | 5 years ago |
Weed Week: Here comes the latest hot take on legal dope from… the Country Women’s Association
Australian cinephiles have two silver screen shows made just for the cannabis crowd to watch. Feature-length film ‘High as Mike’ traces one Tamworth man’s difficult undertaking to access medical cannabis to treat his brain cancer. And the... |
Stockhead | EVE | 5 years ago |
Weed Week: Here comes the latest hot take on legal dope from… the Country Women’s Association
Australian cinephiles have two silver screen shows made just for the cannabis crowd to watch. Feature-length film ‘High as Mike’ traces one Tamworth man’s difficult undertaking to access medical cannabis to treat his brain cancer. And the... |
Stockhead | EVE | 5 years ago |
THC’s Canndeo gets green light to manufacture medicinal cannabis extracts
THC Global’s (ASX: THC) wholly-owned subsidiary Canndeo has achieved a major milestone by securing a manufacturing licence to produce cannabis extracts and tinctures in Australia. The Australian Office of Drug Control granted the licence to... |
SmallCaps | EVE | 5 years ago |
Recent Developments With 5 Pot Stocks- ECS, CPH, THC, EOF And LSH
While several countries across the world are waking up to the benefits of medicalised/legalised marijuana, the industry has boomed rapidly and is one of the fastest growing markets in the world. Meanwhile, Australia’s cannabis market is als... |
Kalkine Media | EVE | 5 years ago |